Monitoring Protocol: Although the trials showed no concerning laboratory changes, prudent clinical practice suggests baseline and periodic monitoring of metabolic parameters, complete blood counts, liver function, and kidney function
Ilic, S., Drmic, D., Franjic, S., Kolenc, D., Coric, M., Brcic, L., Klicek, R., Radic, B., Sever, M., Djuzel, V., Filipovic, M., Djakovic, Z., Stambolija, V., Boban Blagaic, A., Zoricic, I., Gjurasin, M., Stupnisek, M., Romic, Z., Zarkovic, K., Dzidic, S., & Sikiric, P
Every BPC-157 treatment is prescribed by a board-certified physician with specialized training in longevity and peptide therapy, following a clinical evaluation
In November 2023, the FDA added BPC-157 to its list of substances that cannot be used in compounding under the Federal Food, Drug, and Cosmetic Act, citing insufficient safety data for human use 3
Research consistency benefits from established injection protocols
Seek immediate medical attention if any allergic reaction occurs